PE20030190A1 - Conjugados de complejos metalicos macrociclicos con biomoleculas y preparacion de medios de diagnostico que los contienen para resonancia magnetica nuclear, radiodiagnostico y radioterapiaradiodiagnostico y radioterapia - Google Patents

Conjugados de complejos metalicos macrociclicos con biomoleculas y preparacion de medios de diagnostico que los contienen para resonancia magnetica nuclear, radiodiagnostico y radioterapiaradiodiagnostico y radioterapia

Info

Publication number
PE20030190A1
PE20030190A1 PE2002000641A PE2002000641A PE20030190A1 PE 20030190 A1 PE20030190 A1 PE 20030190A1 PE 2002000641 A PE2002000641 A PE 2002000641A PE 2002000641 A PE2002000641 A PE 2002000641A PE 20030190 A1 PE20030190 A1 PE 20030190A1
Authority
PE
Peru
Prior art keywords
radical
atoms
conjugates
optionally
unsaturated
Prior art date
Application number
PE2002000641A
Other languages
English (en)
Inventor
Johannes Platzek
Heribert Schmitt-Willich
Thomas Frenzel
Hans Bauer
Hanns-Joachim Winmann
Heiko Schirmer
Bernd Raduchel
Detlev Sulzle
Gunther Michl
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of PE20030190A1 publication Critical patent/PE20030190A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/14Peptides, e.g. proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0002General or multifunctional contrast agents, e.g. chelated agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/14Peptides, e.g. proteins
    • A61K49/143Peptides, e.g. proteins the protein being an albumin, e.g. HSA, BSA, ovalbumin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

CONJUGADOS DE FORMULA (I), DONDE Z ES H O AL MENOS DOS Z SON UN EQUIVALENTE DE UN ION METALICO; B ES H O UN RADICAL ALQUILO C1-4; R ES H O UN RADICAL ALQUILO C1-10 O ARILO LINEAL RAMIFICADO O CICLICO, SATURADO O INSATURADO SUSTITUIDO OPCIONALMENTE POR UN GRUPO CARBOXILO, -SO3H o -PO3H2; DONDE, LA CADENA C1-10 CONTIENE UN GRUPO ARILO Y/O 1 A 2 ATOMOS DE OXIGENO Y LOS RADICALES B Y R NO REPRESENTAN AL MISMO TIEMPO ATOMOS DE OXIGENO; A ES UNA CADENA DE HIDROCARBUROS C1-30 LINEAL O RAMIFICADA, SATURADA O INSATURADA, QUE TIENE OPCIONALMENTE 1 A 5 ATOMOS DE OXIGENO, 1 A 5 ATOMOS DE NITROGENO Y/O 1 A 5 RADICALES -NR´, DONDE R´ ESTA DEFINIDO COMO R, PERO PUEDE SELECCIONARSE DE MODO INDEPENDIENTE, QUE ESTA OPCIONALMENTE SUSTITUIDO CON 1 A 3 GRUPOS CARBOXILO, 1 A 3 -SO3H, 1 A 3 -PO3H2 Y/O 1 A 3 ATOMOS DE HALOGENO, DONDE ESTAN PRESENTES OPCIONALMENTE 1 A 3 ATOMOS DE C, COMO GRUPOS CARBONILO, ESTANDO A O UNA PARTE DE A DISPUESTA EN FORMA DE ANILLO Y CONFORMADA DE MODO TAL QUE X´ ESTA ENLAZADO A TRAVES DE 3 ATOMOS CON EL ATOMO DE NITROGENO AL QUE ESTA UNIDO A; X´ ES EL RADICAL DE UN GRUPO X QUE REACCIONO CON UNA BIOMOLECULA; Y, Bio ES EL RADICAL DE UNA BIOMOLECULA, SUS SALES CON LA CONDICION DE QUE CUANDO B ES H Y R ES C1-4, A NO ES EL RADICAL DE FOMULA (II), SIENDO R3 UN ATOMO DE H O UN RADICAL ALQUILO C1-4; D ES ALQUILENO C1-4 LINEAL O RAMIFICADO, SATURADO O INSATURADO QUE PUEDE SER SUSTITUIDO POR UN GRUPO CARBONILO Y D ESTA UNIDO A X
PE2002000641A 2001-07-20 2002-07-19 Conjugados de complejos metalicos macrociclicos con biomoleculas y preparacion de medios de diagnostico que los contienen para resonancia magnetica nuclear, radiodiagnostico y radioterapiaradiodiagnostico y radioterapia PE20030190A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10135355A DE10135355C1 (de) 2001-07-20 2001-07-20 Konjugate makrocyclischer Metallkomplexe mit Biomolekülen und deren Verwendung zur Herstellung von Mitteln für die NMR- und Radiodiagnostik sowie die Radiotherapie

Publications (1)

Publication Number Publication Date
PE20030190A1 true PE20030190A1 (es) 2003-03-22

Family

ID=7692470

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2002000641A PE20030190A1 (es) 2001-07-20 2002-07-19 Conjugados de complejos metalicos macrociclicos con biomoleculas y preparacion de medios de diagnostico que los contienen para resonancia magnetica nuclear, radiodiagnostico y radioterapiaradiodiagnostico y radioterapia

Country Status (19)

Country Link
US (2) US20030206865A1 (es)
EP (1) EP1450864A2 (es)
JP (1) JP2004536889A (es)
KR (1) KR20040030825A (es)
CN (1) CN1301750C (es)
AR (1) AR036182A1 (es)
AU (1) AU2002355333B2 (es)
BR (1) BR0211150A (es)
CA (1) CA2453214A1 (es)
DE (1) DE10135355C1 (es)
IL (1) IL159291A0 (es)
MX (1) MXPA04000400A (es)
NO (1) NO20040239L (es)
PE (1) PE20030190A1 (es)
PL (1) PL366421A1 (es)
RU (1) RU2004105262A (es)
TW (1) TWI238722B (es)
UY (1) UY27389A1 (es)
WO (1) WO2003013617A2 (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7067111B1 (en) 1999-10-25 2006-06-27 Board Of Regents, University Of Texas System Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
DK1286704T3 (da) * 2000-06-02 2014-09-22 Univ Texas Ethylendicystein (EC)-glucose analoge konjugater
DE10135356C1 (de) * 2001-07-20 2003-04-17 Schering Ag Makrocyclische Metallkomplexe und deren Verwendung zur Herstellung von Konjugaten mit Biomolekülen
EP1466629A1 (en) 2003-04-11 2004-10-13 BRACCO IMAGING S.p.A. Adducts between magnetic resonance shift reagents and substrates containing exchangeable protons for "CEST" applications
DE10325752A1 (de) * 2003-06-06 2004-12-30 Faustus Forschungs Cie. Translational Cancer Research Gmbh Lektin-Konjugate
FR2856689A1 (fr) * 2003-06-25 2004-12-31 Guerbet Sa Composes specifiques a forte relaxivite
WO2004112840A2 (en) * 2003-06-25 2004-12-29 Guerbet Peptide conjugate for magnetic resonance imaging
US20070258888A1 (en) * 2003-11-17 2007-11-08 Claus Feldmann Contrast Agent for Medical Imaging Techniques and Usage Thereof
US9050378B2 (en) * 2003-12-10 2015-06-09 Board Of Regents, The University Of Texas System N2S2 chelate-targeting ligand conjugates
FR2868320B1 (fr) * 2004-03-31 2007-11-02 Centre Nat Rech Scient Cnrse Agent de contraste pour l'imagerie par resonance magnetique
CA2581639C (en) 2004-09-30 2016-07-26 Molecular Devices Corporation Luminescent lanthanide complexes
WO2006114738A2 (en) * 2005-04-26 2006-11-02 Koninklijke Philips Electronics N.V. Mri contrast agents comprising cest active paramagnetic complex
FI20055712A0 (fi) * 2005-12-29 2005-12-29 Wallac Oy Makrosykliset oligonukleotiidien leimausreagenssit ja niistä johdetut konjugaatit
US8758723B2 (en) * 2006-04-19 2014-06-24 The Board Of Regents Of The University Of Texas System Compositions and methods for cellular imaging and therapy
US10925977B2 (en) * 2006-10-05 2021-02-23 Ceil>Point, LLC Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
BRPI0906797A2 (pt) 2008-01-09 2015-07-14 Molecular Insight Pharm Inc Inibidores de anidrase carbônica ix
WO2010065906A2 (en) 2008-12-05 2010-06-10 Molecular Insight Pharmaceuticals, Inc. Ca-ix specific radiopharmaceuticals for the treatment and imaging of cancer
RU2539565C2 (ru) 2008-12-05 2015-01-20 Моликьюлар Инсайт Фармасьютикалз, Инк. Са-ix специфические радиофармпрепараты для лечения и визуалазиции злокачественных опухолей
EP2706057B1 (en) 2008-12-05 2016-04-20 Molecular Insight Pharmaceuticals, Inc. Bis(imidazolyl)compounds and radionuclide complexes
BR112012000209B8 (pt) 2009-06-15 2021-07-27 Molecular Insight Pharm Inc heterodímeros de ácido glutâmico e seus processos de preparação
CN101912623B (zh) * 2010-08-24 2012-06-06 上海师范大学 具有靶向功能铁-钆双模式磁共振造影剂的制备及应用
CN102136339B (zh) * 2011-01-24 2012-05-23 南开大学 一种具有铁磁、铁电双功能的镝单分子磁体及其制备方法
EP2800471A4 (en) 2012-01-06 2015-11-04 Molecular Insight Pharm Inc METAL COMPLEX OF POLY (CARBOXYL) AMINE CONTAINING LIGANDS HAVING AFFINITY FOR CARBON IX ANHYDRASE
HUE035739T2 (en) 2013-01-14 2018-05-28 Molecular Insight Pharm Inc Triazine-based radiopharmaceuticals and radiological imaging agents
WO2015075699A1 (en) * 2013-11-25 2015-05-28 Sanofi Dotam derivatives for therapeutic use
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
RU2755181C2 (ru) 2016-11-28 2021-09-14 Байер Фарма Акциенгезельшафт Новые хелатные соединения гадолиния с высокой релаксивностью для применения в магнитно-резонансной визуализации
RU2019139432A (ru) 2017-05-05 2021-06-07 Сентр фор Проуб Девелопмент энд Коммерсиализэйшн Фармакокинетическая оптимизация бифункциональных хелатов и их применение
WO2018204872A2 (en) 2017-05-05 2018-11-08 Fusion Pharmaceuticals Inc. Igf-1r monoclonal antibodies and uses thereof
US10093741B1 (en) 2017-05-05 2018-10-09 Fusion Pharmaceuticals Inc. IGF-1R monoclonal antibodies and uses thereof
MX2021006024A (es) 2018-11-23 2021-07-06 Bayer Ag Formulacion de medios de contraste y proceso para prepararlos.
FR3092580B1 (fr) * 2019-02-08 2021-03-19 Centre Nat Rech Scient Nouveaux dérivés azobenzènes, leur procédé de préparation et leur utilisation pour le traitement thérapeutique associé à des radiations ionisantes
EP3757098A1 (en) * 2019-06-25 2020-12-30 Ustav Organicke Chemie a Biochemie AV CR, v.v.i. Cyclen based compounds, coordination compounds, peptides, pharmaceutical preparation, and use thereof
KR102203368B1 (ko) * 2020-10-30 2021-01-14 경북대학교 산학협력단 신규한 화합물 및 이를 함유하는 mri 조영제

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049667A (en) * 1987-04-14 1991-09-17 Guerbet S.A. Nitrogen-containing cyclic ligands
JPH04154729A (ja) * 1990-10-16 1992-05-27 Nippon Mejifuijitsukusu Kk 磁気共鳴造影剤
DE4115789A1 (de) * 1991-05-10 1992-11-12 Schering Ag Makrocyclische polymer-komplexbildner, deren komplexe, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
KR930019648A (ko) * 1992-03-27 1993-10-18 도키 가츠유키 테트라아자시클로도덴칸 유도체 및 그의 용도
KR100312357B1 (ko) * 1992-12-09 2002-04-24 데이비드 이. 프랭크하우저 안정화된약제의에어로졸용액제제
US6693190B1 (en) * 1994-05-11 2004-02-17 Bracco International B.V. Enhanced relaxivity monomeric and multimeric compounds
US6045776A (en) * 1996-12-04 2000-04-04 Schering Aktiengesellschaft Process for the production of metal-complex carboxylic acid amides
US6113880A (en) * 1997-12-17 2000-09-05 Schering Aktiengesellschaft Polyrotaxane derivatives for x-ray and nuclear magnetic resonance imaging
DE19905094C1 (de) * 1999-02-01 2000-10-12 Schering Ag Gadolinium (III)-Komplexe sowie ihre Verwendung für Zweischritt Strahlentherapieformen und diese enthaltende pharmazeutische Mittel

Also Published As

Publication number Publication date
UY27389A1 (es) 2003-02-28
EP1450864A2 (de) 2004-09-01
DE10135355C1 (de) 2003-04-17
MXPA04000400A (es) 2004-03-18
KR20040030825A (ko) 2004-04-09
WO2003013617A2 (de) 2003-02-20
BR0211150A (pt) 2004-06-29
US20070014725A1 (en) 2007-01-18
RU2004105262A (ru) 2005-07-10
AR036182A1 (es) 2004-08-18
TWI238722B (en) 2005-09-01
WO2003013617A3 (de) 2004-06-10
JP2004536889A (ja) 2004-12-09
NO20040239L (no) 2004-01-19
US20030206865A1 (en) 2003-11-06
CN1541114A (zh) 2004-10-27
IL159291A0 (en) 2004-06-01
CA2453214A1 (en) 2003-02-20
AU2002355333B2 (en) 2007-01-04
PL366421A1 (en) 2005-01-24
CN1301750C (zh) 2007-02-28

Similar Documents

Publication Publication Date Title
PE20030190A1 (es) Conjugados de complejos metalicos macrociclicos con biomoleculas y preparacion de medios de diagnostico que los contienen para resonancia magnetica nuclear, radiodiagnostico y radioterapiaradiodiagnostico y radioterapia
HUP0104364A2 (hu) Pirrolidinszármazékok, CCR-3 receptor antagonisták és ezeket tartalmazó gyógyszerkészítmények
ES2056907T3 (es) Compuestos de acridinio que pueden utilizarse como marcadores quimioluminogenos.
CY1105250T1 (el) Μεθοδος θepαπευτικης αγωγης καταστασεων σχετιζομενων με κιναση ρ38 και ενωσεις πυρρολοτριαζινης χρησιμες ως αναστολεις της κινασης
HUP0100568A2 (hu) 11béta-Halogén-7alfa-helyettesített-ösztratriének, alkalmazásuk gyógyászati készítmények előállítására, valamint ilyen vegyületeket tartalmazó gyógyászati készítmények
ES2102478T3 (es) Complejos de vanadio, su preparacion y composiciones farmaceuticas que los contienen.
CO5180568A1 (es) Compuestos farmaceuticos, especialmente mutilinas, composiciones farmaceuticas que los contienen
ES2175834T3 (es) Nuevos analogos tretaciclicos de camptotecinam, sus procedimientos de preparacion, su aplicacion como medicamentos y las composiciones farmaceuticas que los contienen.
AR036183A1 (es) 1,4,7,10-tetraazaciclododecanos, un procedimiento para su preparacion y su uso para la preparacion de un conjugado con una biomolecula
DE3883387T2 (de) Bis(methylendioxy)biphenyl-Verbindungen.
MXPA04002437A (es) Fosfonitos.
ATE220679T1 (de) Porphyrine und ihre verwendung als photosensitizer
SE7706392L (sv) N-fosfonometylenmonoaminoalkanmono- och -polyfosfonsyror respektive n-fosfonometylendiaminoalkanpolyfosfonsyror samt sett for deras framstellning
DE69432497T2 (de) Akridinium Derivate und deren Konjugate
ES2096396T3 (es) Procedimiento para la obtencion de polimeros, formados por alqu-1-enos con 2 a 10 atomos de carbono con empleo de complejos de metaloceno racemicos como catalizadores.
ATE303393T1 (de) Halbsandwich ruthenium(ii)-verbindungen mit einem stickstoff-haltigen liganden zur krebstherapie
FI915916A0 (fi) Tetra-azamakrocykler, foerfaranden foer deras framstaellning och deras anvaendning vid magnetresonans- bildformning.
IT1274038B (it) Chelanti macrociclici loro chelati e relativi usi in campo diagnostico
DK0601191T3 (da) Hidtil ukendt tetracyklisk forbindelse
DE69307310D1 (de) Neue quaternäre ammoniumsalze und deren medizinische verwendung
NO994931L (no) Chelateringsmidler
TW200504177A (en) White lighting chemical compound and fabricating method thereof and white lighting device
ES2170802T3 (es) Carboxamidas biciclicas como ligandos de los receptores 5-ht1a.
DE59003191D1 (de) Oxiran-phenylester und diese enthaltende Fungizide.
DE58902234D1 (de) Alpha-hydroxy-azolylethyloxirane und diese enthaltende fungizide.

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed